CLK2 Expression Is Associated with the Progression of Colorectal Cancer and Is a Prognostic Biomarker
Sign Up to like & getrecommendations! Published in 2022 at "BioMed Research International"
DOI: 10.1155/2022/7250127
Abstract: Background CLK2 is a splicing regulator and expressed ubiquitously in various malignancies. The study is aimed at exploring the potential roles of CLK2 in the development of colorectal cancer (CRC). Methods Real-time PCR and analyses… read more here.
Keywords: expression; prognostic biomarker; colorectal cancer; clk2 ... See more keywords